Cargando…
Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials
AIM: The aim of this study was to summarize the characteristics, efficacy, and safety of vesicular monoamine transporter-2 (VMAT-2) inhibitors for treating tardive dyskinesia (TD). MATERIALS AND METHODS: We conducted a literature search in PubMed, Cochrane Database, and ClinicalTrials.gov, screening...
Autores principales: | Solmi, Marco, Pigato, Giorgio, Kane, John M, Correll, Christoph U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958944/ https://www.ncbi.nlm.nih.gov/pubmed/29795977 http://dx.doi.org/10.2147/DDDT.S133205 |
Ejemplares similares
-
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference
por: Stacy, Mark, et al.
Publicado: (2019) -
Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications
por: Baminiwatta, Anuradha, et al.
Publicado: (2023) -
METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983) -
Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia
por: Sharma, Vibhash D., et al.
Publicado: (2020) -
A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
por: Chadda, R., et al.
Publicado: (1986)